Latest Period
Q1 2026
Security Snapshot
PALISADE BIO, INC. - Common Stock, $0.01 par value per share (PALI) Institutional Ownership
CUSIP: 696389402
13F Institutional Holders and Ownership History from Q2 2024 to Q1 2026
Institutions Reporting
95
Shares (Excl. Options)
146,688,515
Price
$1.75
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.01 par value per share
- Symbol
- PALI on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 146,688,515
- Total 13F value
- $256,823,027
- Portfolio coverage rank
- 0%
- Share change
- +10,598,897
- Value change
- +$12,499,172
- Number of holders
- 95
- Shares outstanding
- 173,216,426
- SEC-reported price per share
- $1.80
- Insider filing price
- $1.80
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PALI - PALISADE BIO, INC. - Common Stock, $0.01 par value per share is tracked under CUSIP 696389402.
- 95 institutions reported positions in Q1 2026.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 87 to 95 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $319,442,849 to $256,823,027.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 95 institutions filings for Q1 2026.
Security key
696389402
Latest holder period
Q1 2026
13F holders
95
13D/G owners
11
CIK / CUSIP context first
Open Q1 2026 holders
PALI full holder history
PALISADE BIO, INC. SEC filings
PALISADE BIO, INC. company facts
PALISADE BIO, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 696389402:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
PALI
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | 0% | $30,835,838 | +$3,278,888 | 17,620,479 | +12% | RA Capital Management, L.P. | 31 Mar 2026 |
| PERCEPTIVE ADVISORS LLC | 10% | 0% | $29,184,225 | +$5,677,630 | 15,200,117 | +24% | Perceptive Advisors LLC | 31 Dec 2025 |
| JANUS HENDERSON GROUP PLC | 10% | $27,835,737 | 14,885,421 | JANUS HENDERSON GROUP PLC | 28 Nov 2025 | |||
| Commodore Capital LP | 7.2% | -27% | $21,641,858 | +$4,683,194 | 12,366,776 | +28% | Commodore Capital LP | 31 Mar 2026 |
| Octagon Capital Advisors LP | 6.4% | $18,370,364 | 9,567,898 | Octagon Capital Advisors LP | 31 Dec 2025 | |||
| Soleus Capital Master Fund, L.P. | 5.4% | $18,239,690 | 9,353,687 | Soleus Capital Master Fund, L.P. | 26 May 2026 | |||
| FRANKLIN RESOURCES INC | 6% | $21,358,511 | 9,163,990 | Franklin Resources, Inc. | 31 Dec 2025 | |||
| AMERIPRISE FINANCIAL INC | 5.3% | $15,244,924 | 8,711,385 | Ameriprise Financial, Inc. | 31 Mar 2026 | |||
| Squadron Capital Management LLC | 3% | -61% | $8,640,000 | -$7,200,000 | 4,500,000 | -45% | Squadron Master Fund LP | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC | 10% | 0% | $335,053 | +$132,407 | 471,906 | +65% | Armistice Capital, LLC | 31 Mar 2025 |
| Point72 Asset Management, L.P. | 0.2% | -97% | $720,601 | -$17,646,090 | 411,772 | -96% | Point72 Asset Management, L.P. | 31 Mar 2026 |
As of 31 Mar 2026, 95 institutional investors reported holding 146,688,515 shares of PALISADE BIO, INC. - Common Stock, $0.01 par value per share (PALI). This represents 85% of the company’s total 173,216,426 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
73%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| B Group, Inc. | 6.6% | 11,414,285 | +154% | 15% | $19,974,999 |
| JANUS HENDERSON GROUP PLC | 6.2% | 10,689,452 | +1.4% | 0.01% | $18,759,988 |
| Octagon Capital Advisors LP | 5.9% | 10,276,317 | +7.4% | 2% | $17,983,555 |
| PERCEPTIVE ADVISORS LLC | 5.2% | 8,928,149 | -26% | 0.31% | $15,624,261 |
| AMERIPRISE FINANCIAL INC | 5% | 8,711,385 | +26% | 0% | $15,244,925 |
| Commodore Capital LP | 4.1% | 7,181,062 | -37% | 0.73% | $12,566,859 |
| RA CAPITAL MANAGEMENT, L.P. | 4.1% | 7,124,116 | 0% | 0.13% | $12,467,203 |
| FRANKLIN RESOURCES INC | 3.3% | 5,785,189 | +14% | 0% | $10,124,081 |
| GOLDMAN SACHS GROUP INC | 3.1% | 5,373,951 | +864% | 0% | $9,404,414 |
| Eversept Partners, LP | 2.9% | 4,987,499 | -7.5% | 0.58% | $8,728,123 |
| Boxer Capital Management, LLC | 2.8% | 4,799,875 | 0% | 1.1% | $8,399,781 |
| MORGAN STANLEY | 2.6% | 4,551,533 | +9.9% | 0% | $7,965,183 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.6% | 4,500,000 | 0% | 0.01% | $7,875,000 |
| GREAT POINT PARTNERS LLC | 2% | 3,405,757 | 1.5% | $5,960,075 | |
| Balyasny Asset Management L.P. | 1.9% | 3,270,845 | +905% | 0.01% | $5,723,979 |
| FEDERATED HERMES, INC. | 1.8% | 3,136,607 | 0.01% | $5,489,062 | |
| Squadron Capital Management LLC | 1.7% | 3,000,000 | -33% | 2.1% | $5,250,000 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.7% | 2,904,911 | 0% | $5,083,594 | |
| MARSHALL WACE, LLP | 1.6% | 2,754,403 | 0.01% | $4,820,209 | |
| Vestal Point Capital, LP | 1.4% | 2,500,000 | 0.12% | $4,375,000 | |
| ORBIMED ADVISORS LLC | 1.3% | 2,333,000 | +25% | 0.09% | $4,082,750 |
| ADAR1 Capital Management, LLC | 1.3% | 2,264,845 | +13% | 0.24% | $3,963,479 |
| MILLENNIUM MANAGEMENT LLC | 1.2% | 2,103,353 | +614% | 0% | $3,680,868 |
| HighVista Strategies LLC | 1.2% | 2,019,326 | +55% | 0.98% | $3,533,820 |
| Artia Global Partners LP | 1.2% | 1,992,367 | 0% | 0.79% | $3,486,642 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
8
Latest
Q1 2026
Rows shown
1-8 of 8
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 146,688,515 | $256,823,027 | +$12,499,172 | $1.75 | 95 |
| 2025 Q4 | 135,909,594 | $319,442,849 | +$306,785,730 | $2.35 | 87 |
| 2025 Q3 | 119,592 | $102,817 | +$30,259 | $0.86 | 12 |
| 2025 Q2 | 84,610 | $57,544 | -$119,036 | $0.68 | 11 |
| 2025 Q1 | 260,593 | $176,598 | -$26,884 | $0.68 | 11 |
| 2024 Q4 | 199,223 | $328,718 | +$210,668 | $1.65 | 9 |
| 2024 Q3 | 62,098 | $220,448 | +$113,672 | $3.55 | 8 |
| 2024 Q2 | 30,078 | $135,352 | +$135,352 | $4.50 | 7 |